# Nuojiang Shengming Keji

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuojiang-shengming-keji

- Industry: Healthcare IT
- Headquarters: Jinan, China
- Total disclosed funding: $2.5M
- Latest round: Angel (Mar 11, 2026)
- Investors on record: 1

## About

Based in Jinan, China and founded in 2022, Nobel Prize Life Science (Shandong) Co., Ltd., trading as Nuojiang Shengming Keji, focuses on integrating international scientific research with AI medical technology to provide precision healthcare solutions. In March 2026, Nuojiang Shengming Keji raised CNY 17.5 million in Angel funding.

The company provides an innovative digital ecosystem that includes AI-driven sub-health clinical research, "smart robot doctors," and a closed-loop service model combining Nobel Prize-winning achievements with grassroots medical empowerment.
The company generates revenue by commercializing its AI medical systems and providing specialized health management services.
The Angel funding raised in March 2026 will be mainly used for the technological iteration of AI medical systems, the commercialization of Nobel Prize-winning achievements, talent team building, and the promotion of grassroots applications.

## Funding rounds

- Angel, Mar 11, 2026, $2.5M — Zhongye Zhengqi (Beijing) International Investment

## Investors

- Zhongye Zhengqi (Beijing) International Investment (https://capitalatlas.ai/funds/zhongye-zhengqi-beijing-international-investment) — Angel